Financial Perspectives’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.7K | Sell |
2,657
-1,894
| -42% | -$46.1K | 0.02% | 277 |
|
|
2025
Q1 | $94.5K | Sell |
4,551
-401
| -8% | -$8.32K | 0.03% | 218 |
|
|
2024
Q4 | $117K | Sell |
4,952
-1,130
| -19% | -$26.6K | 0.04% | 198 |
|
|
2024
Q3 | $156K | Sell |
6,082
-1,050
| -15% | -$26.9K | 0.05% | 160 |
|
|
2024
Q2 | $167K | Hold |
7,132
| – | – | 0.06% | 152 |
|
|
2024
Q1 | $205K | Buy |
7,132
+3
| +0% | +$86 | 0.08% | 138 |
|
|
2023
Q4 | $234K | Hold |
7,129
| – | – | 0.09% | 128 |
|
|
2023
Q3 | $199K | Sell |
7,129
-3
| -0% | -$84 | 0.09% | 125 |
|
|
2023
Q2 | $243K | Buy |
7,132
+306
| +4% | +$10.4K | 0.11% | 112 |
|
|
2023
Q1 | $205K | Hold |
6,826
| – | – | 0.1% | 120 |
|
|
2022
Q4 | $193K | Hold |
6,826
| – | – | 0.1% | 123 |
|
|
2022
Q3 | $224K | Buy |
6,826
+5
| +0.1% | +$164 | 0.13% | 106 |
|
|
2022
Q2 | $215K | Buy |
6,821
+4
| +0.1% | +$126 | 0.12% | 111 |
|
|
2022
Q1 | $313K | Buy |
6,817
+10
| +0.1% | +$459 | 0.15% | 91 |
|
|
2021
Q4 | $417K | Sell |
6,807
-10,575
| -61% | -$648K | 0.2% | 68 |
|
|
2021
Q3 | $1.3M | Buy |
17,382
+7
| +0% | +$523 | 0.65% | 28 |
|
|
2021
Q2 | $1.61M | Sell |
17,375
-1,478,382
| -99% | -$137M | 0.78% | 23 |
|
|
2021
Q1 | $16.9M | Buy |
1,495,757
+1,483,233
| +11,843% | +$16.7M | 0.84% | 19 |
|
|
2020
Q4 | $1.17M | Buy |
12,524
+12,266
| +4,754% | +$1.14M | 0.66% | 26 |
|
|
2020
Q3 | $16.4K | Buy |
+258
| New | +$16.4K | 0.01% | 313 |
|